IDEXX Laboratories ( IDXX ) delivered a very strong quarter and exceeded expectations. With Cancer Dx and InVue , further growth is likely in the future, which is why I consider theMy primary area of concentration will be on identifying companies of exceptional caliber, with a proven ability to reinvest capital for impressive returns. Targeting those with a market capitalization of less than $10 billion, affords ample opportunities for growth. The ideal scenario is for these companies to demonstrate a long- ...

Shares of Idexx Laboratories (IDXX) broke out and catapulted to a record high Monday after the vet diagnostics outlet beat Wall Street's quarterly forecasts and boosted its 2025 outlook. Idexx also earned an adjusted $3.22 per share, ahead of projections for $3.12. Earnings grew 15%. In morning trades, Idexx stock ramped up more than 16% to 725.82. Shares touched their highest-ever point and broke out of a flat base with a buy point at 688.12, according to MarketSurge. Idexx Laboratories And Vet Visits The ...